Mundipharma International Revenue and Competitors

UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Mundipharma International's estimated annual revenue is currently $589.3M per year.(i)
  • Mundipharma International's estimated revenue per employee is $201,000

Employee Data

  • Mundipharma International has 2932 Employees.(i)
  • Mundipharma International grew their employee count by -4% last year.

Mundipharma International's People

NameTitleEmail/Phone
1
VP Talent, Culture and DevelopmentReveal Email/Phone
2
Global Chief Human Resources OfficerReveal Email/Phone
3
Learning, Development & Inclusion DirectorReveal Email/Phone
4
Director TaxReveal Email/Phone
5
Senior Director, Human Resources, Consumer HealthReveal Email/Phone
6
People Director - Global Scientific Affairs, Legal & ComplianceReveal Email/Phone
7
Commercial Director, Global Launch ReadinessReveal Email/Phone
8
Director Communications - Europe and CanadaReveal Email/Phone
9
Senior Compliance Officer, UK, Benelux, Nordics & FranceReveal Email/Phone
10
Senior Director, External CommunicationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Mundipharma International?

Mundipharma is a global (ex-US) network of independent associated companies that research, develop and manufacture innovative pharmaceutical medicines and consumer healthcare products. We are an agile and fast-paced company seeking to increase access to health care through programmes and effective partnerships. \n\nWe are forward-looking and dedicated to bringing innovative treatments to many of the world’s most challenging conditions and diseases including: Pain Management & Supportive Care, Consumer Health, Anti-Infectives, Biosimilars, CNS, Diabetes, Oncology, Ophthalmology, Respiratory and transplantation immunity. \n\nWe make a difference to patient lives by delivering value to healthcare professionals in 120+ countries across Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East.\n\nOur guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do. We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work. \n\nFor more information visit www.mundipharma.com

keywords:N/A

N/A

Total Funding

2932

Number of Employees

$589.3M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mundipharma International News

2022-04-20 - Pegfilgrastim Biosimilar Market is Booming Worldwide with ...

Novartis, Mylan, Coherus BioSciences, Mundipharma International, Biocon, Intas Pharmaceuticals, Pfizer, Dr Reddy's Laboratories.

2022-04-19 - Global Transdermal Drug Patches Market 2022 Expanding ...

Bayer; Mundipharma; Endo International; Beijing Tide Pharmaceutical. The market has been split into the following geographical segments: North...

2022-04-13 - Pain Management Therapeutics Market Report Outlines ...

... Merck & Co., Inc., Mundipharma International Ltd., and Novartis International AG. The research paper examines the global market's past,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1011.2M29369%N/A
#2
$847.5M2953-1%N/A
#3
$909.8M295410%N/A
#4
$744.9M2956N/AN/A
#5
$415M29647%N/A